Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenqi Medical develops and manufactures innovative minimally invasive medical devices for cardiovascular, peripheral vascular, neurovascular interventions, and structural heart diseases. Its flagship program—the SQ-Kyrin Transcatheter Edge-to-edge Valve Repair System—is undergoing multicenter clinical trials for functional mitral regurgitation as of mid–2025. The company also produces drug-coated balloons, embolization systems, microcatheters, guide catheters, and left atrial appendage occluders. It has established partnerships to market its cardiology-related products across Asia-Pacific regions outside China/Japan.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenqi Medical.